Clinical trial
Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
NCT05247112 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 1, 2003
- Completion date
- December 31, 2027
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter pylori 23s rrna clarithromycin resistance mutation, helicobacter pylori associated gastrointestinal disease, helicobacter pylori infection, helicobacter pylori infection, susceptibility to